Alphabet Inc. 13F Portfolio

CIK 1652044 Filing since Q1 2014 Q2 2026 filed Aug 6, 2026
Holdings as of Jun 30, 2026, from the 13F filed Aug 6, 2026.

Portfolio Snapshot

28 positions · Q2 2026

Alphabet Inc. reported 28 positions worth $99.08B for the quarter ended Jun 30, 2026, up 2,367.4% on the prior quarter. It opened 3 new positions, added to 0, trimmed 4 and exited 1. Its largest holding is Space Exploration Technologies Corp at 95% of the portfolio.

Portfolio Value
$99.08B
+2,367.4% QoQ · +5,242.0% YoY
Positions
28
3 new · 1 sold out
Top 10 Concentration
99.5%
of portfolio value
Largest Position
SPCX 95%
Space Exploration Technologies Corp
Net Buying
+$94.28B
$94.36B bought · $78.52M sold
Turnover
0.2%
of the portfolio traded
Top Sector
Industrials
95% of value
Track Record
44
quarters on file since Q1 2014

Portfolio Value & Positions

Value Positions

Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.

Sector Allocation

6 sectors
95.05%
Industrials

Quarterly Buying & Selling

Bought Sold

Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.

Position Changes

How many positions were opened, added to, trimmed or closed each quarter.

Sector Allocation Over Time

Share of reported value in each sector at every quarter end.

Largest Buys

Q2 2026
Holding Change Trade Value Weight
SPCX Space Exploration Technologies Corp +551.19M $94.18B 95.05%
PBLS Parabilis Medicines, Inc. +4.92M $134.65M 0.136%
FRVO Fervo Energy Co +1.76M $51.47M 0.052%

Largest Sells

Q2 2026
Holding Change Trade Value Weight
RVMD Revolution Medicines, Inc. -345.9K -10.5% $64.78M 0.557%
GLUE Monte Rosa Therapeutics, Inc. -311.8K -45.6% $7.55M <0.01%
RLAY Relay Therapeutics, Inc. -154.1K -9.9% $2.88M 0.027%
LIFE Ethos Technologies Inc. -147.6K -3.9% $2.68M 0.066%
TNYA Tenaya Therapeutics, Inc. -915.7K -100.0% $631.84K Exited

New Positions

Q2 2026
Holding Shares Trade Value Weight
SPCX Space Exploration Technologies Corp +551.19M $94.18B 95.05%
PBLS Parabilis Medicines, Inc. +4.92M $134.65M 0.136%
FRVO Fervo Energy Co +1.76M $51.47M 0.052%

Closed Positions

Q2 2026
Holding Shares Sold Trade Value Prior Weight
TNYA Tenaya Therapeutics, Inc. -915.7K $631.84K 0.016%
Holdings · Q2 2026

28 Positions

As ofJun 30, 2026
Value$99.08B
Top 1099.5%
Avg position$3.54B
# Activity
13 more holdings Create a free account to keep reading this institution’s full portfolio.
Showing 1–15 of 28 positions 13F filings on SEC EDGAR

Tip. Select a row to see that position’s full history at Alphabet.

About Alphabet Inc.’s 13F Portfolio

What are Alphabet Inc.’s largest holdings?

As of its Q2 2026 13F filing, Alphabet Inc.’s five largest positions were Space Exploration Technologies Corp (SPCX) at 95.0%, Planet Labs PBC (PL) at 1.2%, AST SpaceMobile, Inc. (ASTS) at 0.8%, Cme Group Inc. (CME) at 0.8%, Arm Holdings Plc (ARM) at 0.7% of the reported portfolio.

How much is Alphabet Inc.’s portfolio worth?

Alphabet Inc. reported a 13F portfolio worth $99.08B across 28 positions for Q2 2026. That is up 2,367.4% from the previous quarter.

What did Alphabet Inc. buy in Q2 2026?

Its largest purchases by value were Space Exploration Technologies Corp ($94.18B), Parabilis Medicines, Inc. ($134.65M), Fervo Energy Co ($51.47M). It opened 3 new positions.

What did Alphabet Inc. sell in Q2 2026?

Its largest sales by value were Revolution Medicines, Inc. ($64.78M), Monte Rosa Therapeutics, Inc. ($7.55M), Relay Therapeutics, Inc. ($2.88M). It exited 1 positions entirely.

Where does this data come from?

From the Form 13F-HR reports Alphabet Inc. files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.

Similar-Sized Institutions

by reported 13F value

13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.